Hints and tips:
...“I’m in the ‘You’ve either got it or you haven’t’ camp,” says Haines....
...Mrs Clinton said on Friday: “Over the past year, we’ve seen far too many examples of drug companies raising prices excessively for longstanding, life-saving treatments with little or no new innovation or R&...
...Innovative Medicines and Early Development, AstraZeneca Steve Bates Chief Executive, BioIndustry Association Harpal Kumar Chief Executive, Cancer Research UK Patrick Vallance President of Pharmaceuticals R&...
...● Hermes Fund Managers has hired Mark Rimme r from Charles Stanley as a fixed income product specialist....
...Roalfe/Y&R, Gary Duckworth, former chairman of DFGW, Chris O’Shea, formerly of FCB Banks Hoggins O’Shea, and wine writer Malcolm Gluck....
International Edition